Trial Profile
A phase I single ascending dose trial of PL 37 in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Dec 2011
Price :
$35
*
At a glance
- Drugs PL 37 (Primary)
- Indications Neuropathic pain
- Focus Adverse reactions
- 25 Nov 2011 Planned number of patients changed to 92.
- 25 Nov 2011 Status changed from not yet recruiting to completed.
- 13 Oct 2008 New trial record.